Document Detail


Published reports of delayed hemolytic anemia after treatment with artesunate for severe malaria - worldwide, 2010-2012.
MedLine Citation:
PMID:  23302816     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Artesunate has been recommended by the World Health Organization (WHO) as the first-line treatment for severe malaria since 2010. It is not licensed in the United States but is available from CDC under an investigational new drug (IND) protocol. During 2010-2012, a total of 19 cases of delayed hemolytic anemia after treatment of severe malaria with artesunate were published in the peer-reviewed medical literature, but no such cases have been reported in the United States. CDC Malaria Branch staff reviewed each published report of delayed hemolysis after artesunate use. Based on the pathogenesis of malaria, the hemolysis likely is a result of severe malaria and not the treatment itself. However, artesunate used in the United States is produced by the U.S. Army Medical Materiel Development Activity, and artesunate used outside of the United States is not. An unrecognized difference might exist between the U.S. artesunate and the artesunate used elsewhere. Alternatively, cases of artesunate-associated hemolysis might have occurred in the United States but were not reported. To better assess these possibilities, CDC has amended the artesunate IND protocol and now recommends that persons treated for severe malaria with artesunate be followed for 4 weeks after treatment and evaluated for hemolytic anemia.
Authors:
Related Documents :
2593716 - Intrathoracic lymphangiomatosis mimicking lymphangioleiomyomatosis in a young woman.
11694916 - Bullae, bronchiectasis and nutritional emphysema in severe anorexia nervosa.
1600356 - Are transient pulmonary solitary nodules a common event in human dirofilariosis?
1585776 - Lung abscess due to pseudallescheria boydii in the course of acute leukaemia. report of...
10900116 - Adenocarcinoma of the esophagus presenting as orbital cellulitis.
16508476 - Neonatal hyperbilirubinemia.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  MMWR. Morbidity and mortality weekly report     Volume:  62     ISSN:  1545-861X     ISO Abbreviation:  MMWR Morb. Mortal. Wkly. Rep.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-01-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7802429     Medline TA:  MMWR Morb Mortal Wkly Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  5-8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Thrombotic Thrombocytopenic Purpura (TTP)-Like Illness Associated with Intravenous Opana ER Abuse - ...
Next Document:  Vital signs: binge drinking among women and high school girls - United States, 2011.